Key facts
- Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G/A for Bright Minds Biosciences Inc. Common Stock, no par value (DRUG).
- Disclosed ownership: 5.2%.
- Date of event: 31 Mar 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 5.2% | 504,645 | 504,645 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner | |
| Vivo Opportunity, LLC | 5.2% | 504,645 | 504,645 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member | |
| Vivo Opportunity Cayman Fund, L.P. | 0.5% | 52,527 | 52,527 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner | |
| Vivo Opportunity Cayman, LLC | 0.5% | 52,527 | 52,527 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member |
CIK / CUSIP context first